IRIS
SAMMARRA, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.082
AS - Asia 630
EU - Europa 446
SA - Sud America 225
Continente sconosciuto - Info sul continente non disponibili 55
AF - Africa 36
OC - Oceania 4
Totale 2.478
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.020
SG - Singapore 253
IT - Italia 237
BR - Brasile 176
CN - Cina 115
VN - Vietnam 108
DE - Germania 63
IN - India 50
CA - Canada 36
HK - Hong Kong 33
FI - Finlandia 29
AR - Argentina 23
GB - Regno Unito 22
BD - Bangladesh 20
ID - Indonesia 16
EG - Egitto 15
EE - Estonia 14
NL - Olanda 14
MX - Messico 11
PL - Polonia 10
CO - Colombia 8
IQ - Iraq 8
SE - Svezia 8
AT - Austria 7
EC - Ecuador 7
FR - Francia 7
ES - Italia 6
JP - Giappone 6
UA - Ucraina 5
CZ - Repubblica Ceca 4
GR - Grecia 4
KR - Corea 4
SC - Seychelles 4
ZA - Sudafrica 4
CL - Cile 3
IE - Irlanda 3
KE - Kenya 3
NI - Nicaragua 3
RU - Federazione Russa 3
UY - Uruguay 3
CI - Costa d'Avorio 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
JO - Giordania 2
LV - Lettonia 2
PK - Pakistan 2
PT - Portogallo 2
RS - Serbia 2
SA - Arabia Saudita 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AL - Albania 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
CH - Svizzera 1
DZ - Algeria 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LT - Lituania 1
MA - Marocco 1
MT - Malta 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
SN - Senegal 1
SV - El Salvador 1
TO - Tonga 1
TR - Turchia 1
TV - Tuvalu 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.424
Salva come PNG Salva come JPEG
Città #
San Jose 174
Dallas 133
Singapore 117
Ashburn 103
Santa Clara 74
Council Bluffs 44
Munich 44
Chandler 37
Ho Chi Minh City 36
Bengaluru 35
Hong Kong 32
Hefei 30
Milan 29
Hanoi 28
Beijing 25
Turku 24
São Paulo 23
Los Angeles 21
New York 21
Rome 20
Chicago 18
Phoenix 17
Orem 12
London 11
San Francisco 11
Aversa 10
Cairo 10
Warsaw 10
Secaucus 9
Boardman 8
Buffalo 8
Miami 8
Bari 7
Denver 7
Florence 7
Pasadena 7
Chennai 6
Lawrence 6
Mexico City 6
Montreal 6
Princeton 6
Rimini 6
Toronto 6
Biên Hòa 5
Boston 5
Helsinki 5
Atlanta 4
Brasília 4
Catanzaro 4
Elk Grove Village 4
Falerna 4
Huế 4
Palermo 4
San Nicola Manfredi 4
Stockholm 4
Surrey 4
Tokyo 4
Vienna 4
Amsterdam 3
Athens 3
Belo Horizonte 3
Bogotá 3
Brooklyn 3
Can Tho 3
Catania 3
Da Nang 3
Genoa 3
Guayaquil 3
Haiphong 3
Isidro Casanova 3
Lamezia Terme 3
Managua 3
Medellín 3
Monza 3
Nairobi 3
Naples 3
North Kansas City 3
Nuremberg 3
Olomouc 3
Posadas 3
Potenza 3
Queens 3
Quảng Ngãi 3
Rio de Janeiro 3
Seattle 3
Turin 3
Wilmington 3
Abidjan 2
Augusta 2
Bakersfield 2
Belgrade 2
Bhubaneswar 2
Bologna 2
Buenos Aires 2
Bắc Giang 2
Bến Cầu 2
Cabo Frio 2
Carney 2
Charlotte 2
City of Westminster 2
Totale 1.428
Salva come PNG Salva come JPEG
Nome #
Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy 160
Effectiveness of perampanel as only concomitant antiseizure medication for highly active epilepsy: insight from a real-world, multicenter retrospective study 112
A brainstem hypermetabolism in a patient with essential palatal tremor: A simultaneous 18F-FDG-PET/3 T-MRI study 111
Glucose transporter-1 deficiency syndrome with extreme phenotypic variability in a five-generation family carrying a novel SLC2A1 variant 106
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program 92
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program 87
Varicella zoster immunity loss in multiple sclerosis patient treated with ocrelizumab 86
Effectiveness and Safety of Adjunctive Cenobamate in People with Focal-Onset Epilepsy: Evidence from the First Interim Analysis of the BLESS Study 85
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program 83
Exome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypes 74
Phenotypic Variability in Novel Doublecortin Gene Variants Associated with Subcortical Band Heterotopia 73
Idiopathic generalized epilepsy in a family with SCN4A-related myotonia 73
Climate change and hyponatremia-related hospital admissions in people with focal epilepsy exposed to carbamazepine or its derivatives 71
Enlarging the clinical spectrum of chorea-acanthocytosis 69
Functional seizures and binge eating disorder: A cross-sectional study 65
Long-term efficacy and safety of secukinumab in real life: a 240 weeks multicenter study from Southern Italy 65
Novel KCNQ2 Variants Related to a Variable Phenotypic Spectrum Ranging from Epilepsy with Auditory Features to Severe Developmental and Epileptic Encephalopathies 65
May anti‐seizure medications alter brain structure in temporal lobe epilepsy? A prospective study 64
Exploring the Effectiveness of Adjunctive Cenobamate in Focal Epilepsy: A Time-Based Analysis 64
Genome-wide association meta-analyses of drug-resistant epilepsy 61
The impact of one-year COVID-19 containment measures in patients with mesial temporal lobe epilepsy: A longitudinal survey-based study 61
Personality disorders in individuals with functional seizures: a systematic review 59
Quantitative analysis of visually normal EEG reveals spectral power abnormalities in temporal lobe epilepsy 59
Value of multimodal imaging approach to diagnosis of neurosarcoidosis 59
Two Novel Variants in the CHRNA2 and SCN2A Genes in Italian Patients with Febrile Seizures 58
Focal epilepsy with sensory seizures associated with arginine:glycine amidinotransferase deficiency: A clinical and advanced magnetic resonance imaging study 54
A Quantitative EEG Signal Analysis Approach for the Evaluation of Neurophysiological Changes Associated with Mesial Temporal Lobe Epilepsy 54
Epilepsy, Immunity and Neuropsychiatric Disorders 50
Looking for indicative magnetic resonance imaging signs of hippocampal developmental abnormalities in patients with mesial temporal lobe epilepsy and healthy controls 48
Non-Coding RNAs: New Biomarkers and Therapeutic Targets for Temporal Lobe Epilepsy 46
Post-Stroke Asymmetric Prurigo Nodularis Responding to Dupilumab Treatment: A Case Report 45
Neuropsychiatric profile in average intelligent individuals with coexisting epilepsy and psychogenic non-epileptic seizures 44
Tremor as an intrinsic feature of juvenile myoclonic epilepsy 42
Clinical predictors and concomitant antiseizure medications effects on seizure control in relation to plasma cenobamate concentration: a multicenter retrospective study 38
Do Cenobamate Pharmacokinetics Change with Co-Administered Antiseizure Medications? An Exploratory Analysis of Responder Patients with Focal Drug-Resistant Epilepsy 26
The bidirectional association of epilepsy with Alzheimer's disease and other neurodegenerative dementias: A longitudinal observational study on the UK Biobank 17
Nabiximols improves sleep architecture in multiple sclerosis: A prospective polysomnographic study 17
Cenobamate Improves Emotional Dysregulation, Impulsivity, and Apathy in Drug-Resistant Focal Epilepsy: A Longitudinal Neuropsychological Study 12
Impact of Age on the Diagnostic Yield of Routine EEG in People With Childhood or Juvenile Absence Epilepsy: A Cross‐Sectional Study 12
Generation of hiPSCs lines from PRICKLE2-mutant individuals with epilepsy 10
Risk of epilepsy in people with adult-onset hydrocephalus: insights from the UK Biobank 1
Totale 2.478
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.273
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.273
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202216 0 0 0 3 0 0 2 2 4 0 4 1
2022/202381 13 18 8 7 5 7 1 8 7 2 2 3
2023/202464 7 10 6 3 2 9 0 9 7 2 0 9
2024/2025490 16 4 6 48 39 56 31 26 40 27 63 134
2025/20261.428 73 133 232 248 98 52 104 87 160 130 80 31
2026/2027389 34 120 156 79 0 0 0 0 0 0 0 0
Totale 2.478